InvestorsHub Logo
Followers 0
Posts 157
Boards Moderated 0
Alias Born 04/12/2011

Re: TheOcho post# 19260

Wednesday, 05/04/2011 10:04:58 AM

Wednesday, May 04, 2011 10:04:58 AM

Post# of 285655
This is the most interesting thing about KBLB's work with SIAL. KBLB does not have to do anything to make money. They could select the "core" business they intend to address for the shareholder, and still, through SIAL generate additional revenues when third party researchers buy and use KBLB's gene mods to test for use in their companies products...If KBLB thinks they are best suited to keep the biomedical properties developed for use in their own human therapeutic applications then great. They can focus on development of micro-sugical sutures, while licensing out their other developments to chip developers, DOD contractors, etc...

Very interesting, maybe we hear more about this in the CC.

RU
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KBLB News